Cargando…

An Efficiently Cleaved HIV-1 Clade C Env Selectively Binds to Neutralizing Antibodies

An ideal HIV-1 Env immunogen is expected to mimic the native trimeric conformation for inducing broadly neutralizing antibody responses. The native conformation is dependent on efficient cleavage of HIV-1 Env. The clade B isolate, JRFL Env is efficiently cleaved when expressed on the cell surface. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boliar, Saikat, Das, Supratik, Bansal, Manish, Shukla, Brihaspati N., Patil, Shilpa, Shrivastava, Tripti, Samal, Sweety, Goswami, Sandeep, King, C. Richter, Bhattacharya, Jayanta, Chakrabarti, Bimal K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379091/ https://www.ncbi.nlm.nih.gov/pubmed/25822521 http://dx.doi.org/10.1371/journal.pone.0122443

Ejemplares similares

Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 and C2 domain-dependent conformational epitopes
por: Das, Supratik, et al.
Publicado: (2016)

Cell surface ectodomain integrity of a subset of functional HIV-1 envelopes is dependent on a conserved hydrophilic domain containing region in their C-terminal tail
por: Samal, Sweety, et al.
Publicado: (2018)

Method to identify efficiently cleaved, membrane-bound, functional HIV-1 (Human Immunodeficiency Virus-1) envelopes
por: Samal, Sweety, et al.
Publicado: (2019)

Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein
por: Ahmed, Shubbir, et al.
Publicado: (2017)

Association of mutations in V3/C3 domain with enhanced sensitivity of HIV-1 clade C primary envelopes to autologous broadly neutralizing plasma antibodies
por: Deshpande, Suprit, et al.
Publicado: (2016)

Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes
por: Kumar, Rajesh, et al.
Publicado: (2017)

Efficiently cleaved HIV-1 envelopes: can they be important for vaccine immunogen development?
por: Das, Supratik, et al.
Publicado: (2020)

Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives
por: Parray, Hilal Ahmed, et al.
Publicado: (2020)

Correction: Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity in vivo
por: Samal, Sweety, et al.
Publicado: (2021)

Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection
por: Kumar, Rajesh, et al.
Publicado: (2020)

Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection
por: Ringe, Rajesh, et al.
Publicado: (2010)

HIV-1 neutralizing antibodies display dual specificity for the primary and coreceptor binding sites and preferential recognition of fully-cleaved Env
por: Li, Y, et al.
Publicado: (2012)

Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer
por: Sarkar, Anita, et al.
Publicado: (2018)

HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms
por: Deshpande, Suprit, et al.
Publicado: (2016)

Elicitation of potent serum neutralizing antibody responses in rabbits by immunization with an HIV-1 clade C trimeric Env derived from an Indian elite neutralizer
por: Kumar, Rajesh, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitro
por: Vishwakarma, Preeti, et al.
Publicado: (2021)

Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library
por: Parray, Hilal Ahmad, et al.
Publicado: (2020)

Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections
por: Parray, Hilal Ahmad, et al.
Publicado: (2021)

Envés
por: Amara, Luigi, 1971-
Publicado: (2003)

Lnc(ing)RNAs to the “shock and kill” strategy for HIV-1 cure
por: Boliar, Saikat, et al.
Publicado: (2021)

Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates
por: Sundling, Christopher, et al.
Publicado: (2010)

Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates
por: Sundling, Christopher, et al.
Publicado: (2010)

Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability
por: Mason, Rosemarie D., et al.
Publicado: (2016)

Altering an Artificial Gagpolnef Polyprotein and Mode of ENV Co-Administration Affects the Immunogenicity of a Clade C HIV DNA Vaccine
por: Böckl, Katharina, et al.
Publicado: (2012)

Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability
por: Mason, Rosemarie D., et al.
Publicado: (2016)

Key Positions of HIV-1 Env and Signatures of Vaccine Efficacy Show Gradual Reduction of Population Founder Effects at the Clade and Regional Levels
por: Han, Changze, et al.
Publicado: (2020)

A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
por: Sanders, Rogier W., et al.
Publicado: (2013)

Editorial: Long non-coding RNAs in viral infections and immunity
por: Boliar, Saikat, et al.
Publicado: (2023)

Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges
por: Khattar, Sunil K., et al.
Publicado: (2015)

SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys
por: Humbert, Michael, et al.
Publicado: (2008)

Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques
por: Negri, Donatella, et al.
Publicado: (2016)

Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein
por: Alexander, J, et al.
Publicado: (2012)

Cleaving and migrating
por: Wells, William A.
Publicado: (2001)

R5 Clade C SHIV Strains with Tier 1 or 2 Neutralization Sensitivity: Tools to Dissect Env Evolution and to Develop AIDS Vaccines in Primate Models
por: Siddappa, Nagadenahalli B., et al.
Publicado: (2010)

The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41
por: Perween, Reshma, et al.
Publicado: (2021)

Maternal intranasal immunization with HTLV-1 Env induces Env specific antibody responses in breast milk
por: Suzuki, Tadaki
Publicado: (2015)

Intrathecal tramadol added to bupivacaine as spinal anesthetic increases analgesic effect of the spinal blockade after major gynecological surgeries
por: Chakraborty, Susmita, et al.
Publicado: (2008)

T-Cell Immune Responses Against Env from CRF12_BF and Subtype B HIV-1 Show High Clade-Specificity that Can Be Overridden by Multiclade Immunizations
por: Mónaco, Daniela C., et al.
Publicado: (2011)

In vitro selection of small RNA-cleaving deoxyribozymes that cleave pyrimidine–pyrimidine junctions
por: Schlosser, Kenny, et al.
Publicado: (2008)

Vista envés de un cuerpo /
por: Homero, José, 1965-
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_vti2iiekh28ahni1nb41ub901j